Pricing
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (5)
Unverified
Nickolay V. Kukekov
0 people · 0 jobs
HQ
Astellas Pharma
48 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
499 followers
Bayer
424 followers
Bristol-Myers Squibb
291 followers
UCB
74 followers
NYU Langone Health
38 followers
Perrigo
West Pharmaceutical Services
11 followers
Dechra Pharmaceuticals
9 followers
View more